Search research articles
Contact Us
Filters
Showing results (21-30 of 134) with videos related to
Page
of 14
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 26, 2021
Small vessel vasculitis related to varicella-zoster virus after Pfizer-BioNTech COVID-19 vaccine
F Nastro, G Fabbrocini, F di Vico, et al.
Clinical and Experimental Dermatology
|
October 4, 2018
Homocysteine plasma levels in patients affected by hidradenitis suppurativa: an Italian experience
C Marasca, M Donnarumma, M C Annunziata, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 21, 2009
Sun prevention and information technology
G Fabbrocini, V Battimiello, A Monfrecola, et al.
Clinical and Experimental Dermatology
|
June 3, 2009
Acne scarring treatment using skin needling
G Fabbrocini, N Fardella, A Monfrecola, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 13, 2019
Efficacy and safety of ixekizumab in a group of 16 elderly patients with psoriasis over a 1-year period
M Megna, E Cinelli, A Balato, et al.
The Journal of Dermatological Treatment
|
April 3, 2020
Secukinumab during pregnancy: a case report and review of literature
L Gallo, A Ruggiero, A Balato, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 24, 2022
Atopic dermatitis exacerbation after Covid-19 vaccination in Dupilumab-treated patients
L Potestio, M Napolitano, L Bennardo, et al.
Clinical and Experimental Dermatology
|
May 17, 2020
Advanced basal cell carcinoma treated with vismodegib: impact on the lives of patients and their families
A Villani, M Cappello, C Costa, et al.
The Journal of Dermatological Treatment
|
May 19, 2020
The effectiveness of vismodegib in patients with advanced periocular basal cell carcinoma: a case series of 13 patients
A Villani, C Costa, M Cappello, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 22, 2020
Second primary melanoma: incidence rate and risk factors
A Villani, G Fabbrocini, C Costa, et al.
Page
of 14
Search research articles
Search
Showing results (21-30 of 134) with videos related to
Sort By:
Page
of 14
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 26, 2021
Small vessel vasculitis related to varicella-zoster virus after Pfizer-BioNTech COVID-19 vaccine
F Nastro, G Fabbrocini, F di Vico, et al.
Clinical and Experimental Dermatology
|
October 4, 2018
Homocysteine plasma levels in patients affected by hidradenitis suppurativa: an Italian experience
C Marasca, M Donnarumma, M C Annunziata, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 21, 2009
Sun prevention and information technology
G Fabbrocini, V Battimiello, A Monfrecola, et al.
Clinical and Experimental Dermatology
|
June 3, 2009
Acne scarring treatment using skin needling
G Fabbrocini, N Fardella, A Monfrecola, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 13, 2019
Efficacy and safety of ixekizumab in a group of 16 elderly patients with psoriasis over a 1-year period
M Megna, E Cinelli, A Balato, et al.
The Journal of Dermatological Treatment
|
April 3, 2020
Secukinumab during pregnancy: a case report and review of literature
L Gallo, A Ruggiero, A Balato, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 24, 2022
Atopic dermatitis exacerbation after Covid-19 vaccination in Dupilumab-treated patients
L Potestio, M Napolitano, L Bennardo, et al.
Clinical and Experimental Dermatology
|
May 17, 2020
Advanced basal cell carcinoma treated with vismodegib: impact on the lives of patients and their families
A Villani, M Cappello, C Costa, et al.
The Journal of Dermatological Treatment
|
May 19, 2020
The effectiveness of vismodegib in patients with advanced periocular basal cell carcinoma: a case series of 13 patients
A Villani, C Costa, M Cappello, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 22, 2020
Second primary melanoma: incidence rate and risk factors
A Villani, G Fabbrocini, C Costa, et al.
Page
of 14